Cargando…

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results

Detalles Bibliográficos
Autores principales: Labadzhyan, Artak, Nachtigall, L B, Fleseriu, M, Gordon, M B, Molitch, M, Kennedy, L, Samson, S L, Greenman, Y, Biermasz, N, Bolanowski, M, Haviv, A, Ludlam, W, Patou, G, Strasburger, C J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550488/
https://www.ncbi.nlm.nih.gov/pubmed/34347226
http://dx.doi.org/10.1007/s11102-021-01177-w
_version_ 1784590969852657664
author Labadzhyan, Artak
Nachtigall, L B
Fleseriu, M
Gordon, M B
Molitch, M
Kennedy, L
Samson, S L
Greenman, Y
Biermasz, N
Bolanowski, M
Haviv, A
Ludlam, W
Patou, G
Strasburger, C J
author_facet Labadzhyan, Artak
Nachtigall, L B
Fleseriu, M
Gordon, M B
Molitch, M
Kennedy, L
Samson, S L
Greenman, Y
Biermasz, N
Bolanowski, M
Haviv, A
Ludlam, W
Patou, G
Strasburger, C J
author_sort Labadzhyan, Artak
collection PubMed
description
format Online
Article
Text
id pubmed-8550488
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85504882021-10-29 Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results Labadzhyan, Artak Nachtigall, L B Fleseriu, M Gordon, M B Molitch, M Kennedy, L Samson, S L Greenman, Y Biermasz, N Bolanowski, M Haviv, A Ludlam, W Patou, G Strasburger, C J Pituitary Correction Springer US 2021-08-04 2021 /pmc/articles/PMC8550488/ /pubmed/34347226 http://dx.doi.org/10.1007/s11102-021-01177-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Labadzhyan, Artak
Nachtigall, L B
Fleseriu, M
Gordon, M B
Molitch, M
Kennedy, L
Samson, S L
Greenman, Y
Biermasz, N
Bolanowski, M
Haviv, A
Ludlam, W
Patou, G
Strasburger, C J
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
title Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
title_full Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
title_fullStr Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
title_full_unstemmed Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
title_short Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
title_sort correction to: oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550488/
https://www.ncbi.nlm.nih.gov/pubmed/34347226
http://dx.doi.org/10.1007/s11102-021-01177-w
work_keys_str_mv AT labadzhyanartak correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT nachtigalllb correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT fleserium correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT gordonmb correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT molitchm correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT kennedyl correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT samsonsl correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT greenmany correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT biermaszn correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT bolanowskim correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT haviva correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT ludlamw correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT patoug correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults
AT strasburgercj correctiontooraloctreotidecapsulesforthetreatmentofacromegalycomparisonof2phase3trialresults